EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution

Antoine Garnier-Crussard, François Cotton, Pierre Krolak-Salmon, Gaël Chételat iD

Alzheimer's & Dementia · 2023-08 · 19 (8) · 3738-3748

DOI: 10.1002/alz.13057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 07.04.2023. Verfasst von Antoine Garnier-Crussard und 3 weiteren Autor:innen. Beteiligte Einrichtung: Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders," Neuropresage Team, Cyceron, Caen, France. Hauptthemen laut MEDLINE: Alzheimer Disease, White Matter, Cognitive Dysfunction. Die Arbeit wurde bisher 148-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

White matter hyperintensities (WMH), frequently seen in older adults, are usually considered vascular lesions, and participate in the vascular contribution to cognitive impairment and dementia. However, emerging evidence highlights the heterogeneity of WMH pathophysiology, suggesting that non‐vascular mechanisms could also be involved, notably in Alzheimer's disease (AD). This led to the alternative hypothesis that in AD, part of WMH may be secondary to AD‐related processes. The current perspective brings together the arguments from different fields of research, including neuropathology, neuroimaging and fluid biomarkers, and genetics, in favor of this alternative hypothesis. Possible underlying mechanisms leading to AD‐related WMH, such as AD‐related neurodegeneration or neuroinflammation, are discussed, as well as implications for diagnostic criteria and management of AD. We finally discuss ways to test this hypothesis and remaining challenges. Acknowledging the heterogeneity of WMH and the existence of AD‐related WMH may improve personalized diagnosis and care of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseWhite MatterCognitive DysfunctionHumansAgedMagnetic Resonance ImagingNeuroimaging

Stichwörter der Autor:innen

Alzheimer's diseaseAlzheimer's disease-related white matter hyperintensitiesmixed dementianeurodegenerationwhite matter hyperintensities

Autor:innen und Institutionen

  • Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders," Neuropresage Team, Cyceron, Caen, France.
  • Clinical and Research Memory Center of Lyon, Lyon Institute For Aging, Hospices Civils de Lyon, Villeurbanne, France.
  • Eduwell team, Lyon Neuroscience Research Center (CRNL), INSERM U1028, CNRS UMR5292, UCBL1, Lyon, France.
  • Radiology Department, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France.
  • CREATIS, INSERM U1044, CNRS UMR 5220, UCBL1, Villeurbanne, France.

ORCID-Profile: Gaël Chételat

Zitieren

APA

Garnier-Crussard, A., Cotton, F., Krolak-Salmon, P., & Chételat, G. (2023). White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution. Alzheimer's & Dementia, 19(8), 3738-3748. https://doi.org/10.1002/alz.13057

Vancouver

Garnier-Crussard A, Cotton F, Krolak-Salmon P, Chételat G. White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution. Alzheimer's & Dementia. 2023;19(8):3738-3748. doi:10.1002/alz.13057

BibTeX
@article{GarnierCrussard2023,
  author = {Garnier-Crussard, Antoine and Cotton, François and Krolak-Salmon, Pierre and Chételat, Gaël},
  title = {White matter hyperintensities in Alzheimer's disease: Beyond vascular contribution},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {8},
  pages = {3738--3748},
  doi = {10.1002/alz.13057}
}
Kostenlos starten →